Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?
source: shutterstock.com

Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?

According to reporting from News-Medical.net, Janssen-Cilag International NV recently announced that it had applied for European Medicines Agency (EMA) approval of its drug guselkumab (marketed as TREMFYA) in an expansion…

Continue Reading Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?
STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum
source: shutterstock.com

STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum

On February 28th, 2024, the first-ever White House Rare Disease Forum took place. Hosted by the White House Office of Science and Technology Policy, this forum provided a platform for…

Continue Reading STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum
Canadian Immigrants See Multiple Sclerosis Risk Increase the Longer They Live There
source: shutterstock.com

Canadian Immigrants See Multiple Sclerosis Risk Increase the Longer They Live There

The cause of multiple sclerosis, an autoimmune disorder impacting the nervous system, isn't well understood. Genetics, infectious agents, and environmental factors seem to all play a role, but researchers aren't…

Continue Reading Canadian Immigrants See Multiple Sclerosis Risk Increase the Longer They Live There
Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain
source: shutterstock.com

Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain

According to a story from psypost.org, a treatment approach called transcranial direct current stimulation can help alleviate certain aspects of pain associated with Parkinson's disease. Transcranial direct current stimulation (tDCS)…

Continue Reading Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain
April 30th is the First-Ever AMKD Awareness Day. Here’s What You Need to Know
source: shutterstock.com

April 30th is the First-Ever AMKD Awareness Day. Here’s What You Need to Know

  On April 30, 2024, the American Kidney Fund (AKF) will be organizing the first annual APOL1-mediated kidney disease (AMKD) Awareness Day. This awareness day will be a time to…

Continue Reading April 30th is the First-Ever AMKD Awareness Day. Here’s What You Need to Know
Is the CDC Botching its RSV Vaccine Rollout?
source: shutterstock.com

Is the CDC Botching its RSV Vaccine Rollout?

  • Post author:
  • Post category:RSV

Last fall, a new vaccine for respiratory syncytial virus (RSV) intended for pregnant people was made available to the public. Physician Sarah Turner, who was used to getting some pushback…

Continue Reading Is the CDC Botching its RSV Vaccine Rollout?
First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
source: shutterstock.com

First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring

According to a press release from the US Food and Drug Administration (FDA), the agency has approved the medication resmetirom (marketed as Rezdiffra) as the first-ever treatment intended to treat…

Continue Reading First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
Photo courtesy of Towfiqu Barbhuiya on Unsplash

Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options

Recently, the US Food and Drug Administration (FDA) approved a label expansion for the monoclonal antibody dupilumab (marketed as Dupixent) in the treatment of a rare disease called eosinophilic esophagitis…

Continue Reading Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options